MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts12121413
Avg. Estimate0.240.261.051.22
Low Estimate0.220.2211.09
High Estimate0.270.291.11.54
Year Ago EPS0.260.271.051.05
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
No. of Analysts991413
Avg. Estimate188.97M191.8M769.18M801.89M
Low Estimate187.9M189M759M769M
High Estimate191.95M194.21M787M842M
Year Ago Sales196.5M196.9M771.4M769.18M
Sales Growth (year/est)-3.80%-2.60%-0.30%4.30%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.0.240.230.260.21
EPS Actual0.260.270.30.26
Difference0.020.040.040.05
Surprise %8.30%17.40%15.40%23.80%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Current Estimate0.240.261.051.22
7 Days Ago0.240.261.051.22
30 Days Ago0.240.261.041.21
60 Days Ago0.250.261.031.17
90 Days Ago0.250.261.021.16
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2018)Next Year (2019)
Up Last 7 Days11N/A1
Up Last 30 Days2213
Down Last 30 DaysN/A111
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.-7.70%N/AN/A0.22
Next Qtr.-3.70%N/AN/A0.25
Current YearN/AN/AN/A0.08
Next Year16.20%N/AN/A0.12
Next 5 Years (per annum)11.83%N/AN/A0.10
Past 5 Years (per annum)-12.41%N/AN/AN/A